Search

Search Results

• CO037 | PERFORMANCE OF A QUALITATIVE POINT-OF-CARE TEST IN PATIENTS EXPERIENCING ACUTE THROMBOEMBOLIC OR MAJOR BLEEDING EVENTS TREATED WITH DOACs: THE T-BLEEDOAC MULTICENTER PROSPECTIVE COHORT STUDY M. Vedovati¹, G. Pepe², S. Vanni³, E. Campello⁴, F. Morello⁵, S. Beccatini¹, D. Giudici¹, F. Lucarini², L. Parmeggiani³, G. Fabiani³, P. Simioni⁴, M. Santoro⁵, P. Nazerian⁶, M. Mosconi¹, C. Becattini¹ | ¹University of Perugia, Perugia, Italy; ²Versilia Hospital, Tuscany North West Health System, Lido di Camaiore (LU), Italy; ³Università di Firenze, Firenze, Italy; ⁴University of Padua, Padova, Italy; ⁵A.O.U. Città della Salute e della Scienza, Torino, Italy; ⁶Careggi University Hospital, Firenze, Italy

  Maria Cristina Vedovati

  26-10-2026

  https://doi.org/10.4081/btvb.2026.739

  0

  PDF: 0

• CO001 | DERIVATION AND VALIDATION OF THE BLEEPE SCORE FOR RISK STRATIFICATION OF MAJOR BLEEDING IN PATIENTS WITH ACUTE PULMONARY EMBOLISM M. Vedovati¹, L. Cimini¹, V. Valeriano², I. Montenovo¹, A. Murgia³, L. Pierpaoli⁴, G. Tratar⁵, S. Zaccaroni⁶, A. Bongarzoni⁷, A. Vinci¹, A. Mavri⁵, L. Martinelli⁸, G. Pepe⁹, S. Cozzio¹⁰, C. Becattini¹ | ¹University of Perugia, Perugia, Italy; ²Sandro Pertini Hospital, Roma, Italy; ³SS. Annunziata Hospital, Sassari, Italy; ⁴S. Maria delle Croci Hospital, Ravenna, Italy; ⁵University Medical Centre Ljubljana, Ljubljana, Slovenia; ⁶Maggiore Hospital, Bologna, Italy; ⁷ASST Santi Paolo e Carlo-PO San Carlo, Milano, Italy; ⁸Città di Castello Hospital, Città di Castello, Italy; ⁹Versilia Hospital, Tuscany North West Health System, Lido di Camaiore (LU), Italy; ¹⁰Rovereto Hospital, Rovereto, Italy

  Maria Cristina Vedovati

  26-10-2026

  https://doi.org/10.4081/btvb.2026.703

  2

  PDF: 0

• CO042 | BLEEDING RISK IN PATIENTS RECEIVING CONCURRENT TREATMENT WITH DIRECT ORAL ANTICOAGULANTS AND CORTICOSTEROIDS: A SYSTEMATIC REVIEW M.A. Capparella¹, R. Talerico², C. Cavallaro², M. Iorio², F. Bossi¹, A. Porfidia², K. Abe³, M. Biglietto⁴, A. Chistolini⁴, A. Holt⁵, L. Lahousse^6|7, R. Pola², C. Becattini¹, M.C. Vedovati¹ | ¹Internal, Vascular and Emergency Medicine – Stroke Unit, University of Perugia, Italy; ²Thrombosis Unit, Department of Geriatric, Orthopedic, and Rheumatologic Sciences, Fondazione Policlinico A. Gemelli IRCCS, Roma, Italy; ³Division of Gastroenterology, Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan; ⁴Hematology, Department of Translational and Precision Medicine, Sapienza University of Roma, Italy; ⁵Department of Cardiology, Copenhagen University Hospital – Herlev and Gentofte, Copenhagen, Denmark; ⁶Department of Bioanalysis, Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium; ⁷Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands

  Maria Alessandra Capparella

  26-10-2026

  https://doi.org/10.4081/btvb.2026.744

  0

  PDF: 0

• CO012 | LONG-TERM RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN ADULT PATIENTS WITH ACTIVE CANCER AND FIRST CATHETER-RELATED UPPER EXTREMITY DEEP VEIN THROMBOSIS AFTER DISCONTINUATION OF ANTICOAGULANT TREATMENTS AND LINE REMOVAL: A RETROSPECTIVE MULTI-CENTER COHORT STUDY – CANCER-CRT STUDY L. Girardi^1|2, W. Ageno³, L. Bertù¹, C. Lodigiani⁴, L.A. Ciuffini⁴, M.C. Vedovati⁵, C. Becattini⁵, A. Sammarco⁶, G. Camporese⁶, G. Cuni^1|7, C. Ambaglio⁷, M.P. Donadini¹ | ¹Research Center on Thromboembolic Diseases and Antithrombotic Treatment, Department of Medicine and Surgery, University of Insubria, Varese, Italy; ²Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada; ³Department of Medicine, University of Padua, Padova, Italy; ⁴Center for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy; ⁵Internal and Cardiovascular Medicine-Stroke Unit, University of Perugia, Perugia, Italy; ⁶Clinica Medica 1, Department of Medicine, DIMED, Padova University Hospital, Padova, Italy; ⁷Immunohematology and Transfusion Medicine, Department of Transfusion Medicine and Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy

  Laura Girardi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.714

  0

  PDF: 0

• CO046 | BLEEDING RISK FACTOR–BASED PHENOTYPES AND THEIR ASSOCIATION WITH MORTALITY AND HEMORRHAGIC OUTCOMES IN ATRIAL FIBRILLATION T. Bucci¹, A.G. Rigutini¹, A. Perrotta¹, A. Moffa¹, C. Seviroli¹, M. Giustozzi², M.C. Vedovati¹, C. Becattini¹ | ¹Internal, Vascular and Emergency Medicine - Stroke Unit, University of Perugia, Perugia, Italy; ²SSD Angiology, San Giovanni Battista Hospital, Foligno, Italy

  Tommaso Bucci

  26-10-2026

  https://doi.org/10.4081/btvb.2026.748

  0

  PDF: 0

• CO050 | INTERACTION BETWEEN DIRECT ORAL ANTICOAGULANTS AND ANTIEPILEPTIC DRUGS: A MULTICENTER OBSERVATIONAL STUDY A. Lipari¹, S. Sorrentino¹, M. De Siati¹, L. D'Innocenzo¹, A. Ferretti¹, D. Menichelli², V. Cammisotto², P. Pignatelli², G. Ragna³, MC. Vedovati³, C. Becattini³, G. Frisullo⁴, V. Forte⁵, T. Pirozzi¹, L. Di Gennaro¹, M. Basso¹, E. De Candia¹ | ¹Unit of Haemostasis and Thrombosis Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; ²Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Roma, Roma, Italy; ³Department of Internal and Cardiovascular Medicine and Stroke Unit, University of Perugia, Perugia, Italy; ⁴Dipartimento di Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; ⁵Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Roma, Italy

  Silvia Sorrentino

  26-10-2026

  https://doi.org/10.4081/btvb.2026.752

  0

  PDF: 1

• PO105 | IMPACT OF ECOG PERFORMANCE STATUS ON CANCER-ASSOCIATED THROMBOSIS TREATED WITH DOACS: DATA FROM A MULTICENTER COHORT STUDY R. Talerico¹, F. Mancinetti¹, C. Sacco², M. Mazzetti³, E. Campello⁴, S. Birocchi⁵, S. Beccatini⁶, A. Porfidia¹, C. Lodigiani², P. Simioni⁴, G.M. Podda⁵, I. Mastandrea², C. Becattini⁶, R. Pola¹, M.C. Vedovati⁶ | ¹Thrombosis Unit, Department of Geriatric, Orthopedic, and Rheumatologic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; ²Thrombosis and Hemorrhagic Diseases Unit, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy; ³Interdisciplinary Internal Medicine, Careggi University Hospital, Firenze, Italy; ⁴First Chair of Internal Medicine and Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, University of Padova, Italy; ⁵Medicine II Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milano, Milano, Italy; ⁶Internal, Vascular and Emergency Medicine– Stroke Unit, University of Perugia, Perugia, Italy

  Rosa Talerico

  26-10-2026

  https://doi.org/10.4081/btvb.2026.921

  0

  PDF: 0